Treatment of substance abuse during pregnancy

Women's Health

Volumn 4, Issue 1, 2008, Pages 67-77

  Lester, Barry M ^a   Twomey, Jean E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Pregnancy; Substance abuse; Treatment

Indexed keywords

BUPRENORPHINE; COCAINE; ILLICIT DRUG; METHADONE;

ANXIETY DISORDER; ATTITUDE TO MENTAL ILLNESS; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED PRACTICE; HEALTH PROGRAM; HOME CARE; HUMAN; LEGAL ASPECT; MATERNAL ATTITUDE; MENTAL HEALTH SERVICE; MOOD DISORDER; MOTHER CHILD RELATION; OUTCOMES RESEARCH; PATIENT COUNSELING; PATIENT PARTICIPATION; PREGNANCY; PRENATAL CARE; PSYCHOLOGIC TEST; REVIEW; TREATMENT DURATION; WITHDRAWAL SYNDROME; WOMEN'S HEALTH;

EVIDENCE-BASED MEDICINE; FEMALE; HOME CARE SERVICES; HUMANS; MOTHER-CHILD RELATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; RESIDENTIAL TREATMENT; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 38049138892     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.4.1.67     Document Type: Review

References (78)

1. Chasnoff IJ, Anson A, Hatcher R et al.: Prenatal exposure to cocaine and other drugs. Outcome at four to six years. Ann. NY Acad. Sci. 846, 314-328 (1998).
2. Volkow N: The addicted human brain: insights from imaging studies. J. Clin. Invest. 111(10), 1444-1451 (2003).
3. Wingfield K: Alcohol and Other Drug Survey of State Child Welfare Agencies. Child Welfare League of America. Also available at www.cwla.org.
4. Young N, Gardner S, Dennis K. In: Responding to Alcohol and Other Drug Problem in Child Welfare: Weaving Together Practice and Policy. CWLA Press, Washington, DC, USA (1998).
5. No Safe Haven: Children of Substance-Abusing Parents. National Center on Addiction and Substance Abuse at Columbia University, NY, USA (1999).
6. Chaffin M, Kelleher K, Hollenberg J: Onset of physical abuse and neglect: psychiatric, substance abuse, and social risk factors from prospective community data. Child Abuse Negl. 20(3), 191-203 (1996).
7. US Department of Health and Human Services: Blending Perspectives and Building Common Ground. Report to Congress on Substance Abuse and Child Protection. US Government Printing Office, Washington, DC, USA (1999).
8. Jackson C, Henricksen L, Dickinson D, Levine D: The early use of alcohol and tobacco: its relation to children's competence and parents' behavior. Am. J. Public Health 87, 359-364 (1997).
9. Kaplow JB, Curran PJ, Dodge KA: Child, parent, and peer predictors of early-onset substance use: a multisite longitudinal study. J. Abnorm. Child Psychol. 30(3), 199-216 (2002).
10. Biederman J, Faraone S, Monuteaux M, Feighner J: Patterns of alcohol and drug use in adolescents can be predicted by parental substance use disorders. Pediatrics 106(4), 792-797 (2000).
11. Leshner A: Addiction is a brain disease, and it matters. Science 278, 45-52 (1997).
12. Volkow ND, Fowler JS, Wang GJ, Swanson JM: Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 9(6), 557-569 (2004).
13. Lester BM, ElSohly M, Wright LL et al.: The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 107(2), 309-317 (2001).
14. Finkelstein N: Treatment programming for alcohol and drug-dependent pregnant women. Int. J. Addict. 28(13), 1275-1309 (1993).
15. Chasnoff IJ, McGourty RF, Bailey GW et al.: The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes. J. Perinatol. 25(6), 368-374 (2005).
16. Curet LB, Hsi AC: Drug abuse during pregnancy. Clin. Obstet. Gynecol. 45(1), 73-88 (2002).
17. Ebrahim SH, Groerer J: Pregnancy-related substance use in the United States during 1996-1998. Obstet. Gynecol. 101(2), 374-379 (2003).
18. Haller D, Miles D, Dawson K: Factors influencing treatment enrollment by pregnant substance abusers. Am. J. Drug Alcohol Abuse 29(1), 117-131 (2003).
19. Greenfield L, Burgdorf K, Chen X et al.: Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies. Am. J. Drug Alcohol Abuse 30(3), 537-550 (2004).
20. Conners NA, Grant A, Crone CC, Whiteside-Mansell L: Substance abuse treatment for mothers: treatment outcomes and the impact of length of stay. J. Subst. Abuse Treat. 31(4), 447-456 (2006).
21. Chen X, Burgdorf K, Dowell K et al.: Factors associated with retention of drug abusing women in long-term residential treatment. Eval. Program Plann. 27(2), 205-212 (2004).
22. Ashley OS, Marsden ME, Brady TM: Effectiveness of substance abuse treatment programming for women: a review. Am. J. Drug Alcohol Abuse 29(1), 19-53 (2003).
23. Dakof GA, Quille TJ, Tejeda MJ et al.: Enrolling and retaining mothers of substance-exposed infants in drug abuse treatment. J. Consult. Clin. Psychol. 71(4), 764-772 (2003).
24. Jessup M, Humphreys J, Brindis C, Lee K: Extrinsic barriers to substance abuse treatment among pregnant drug dependent women. J. Drug Issues 33(2), 285-304 (2003).
25. Haller DL, Miles DR, Dawson KS: Psychopathology influences treatment retention among drug-dependent women. J. Subst. Abuse Treat 23(4), 431-436 (2002).
26. Ingersoll KS, Knisely JS, Dawson KS, Schnoll SH: Psychopathology and treatment outcome of drug dependent women in a perinatal program. Addict. Behav. 29(4), 731-741 (2004).
27. Fitzsimons HE, Tuten M, Vaidya V, Jones HE: Mood disorders affect drug treatment success of drug-dependent pregnant women. J. Subst. Abuse Treat. 32(1), 19-25 (2007).
28. Kissin WB, Svikis DS, Moylan P, Haug NA, Stitzer ML: Identifying pregnant women at risk for early attrition from substance abuse treatment. J. Subst. Abuse Treat 27(1), 31-38 (2004).
29. Burgdorf K, Xiaowu C, Walker T, Porowski A, Herrell J: The prevalence and prognostic significance of sexual abuse in substance abuse treatment of women. Addictive Disorders & Their Treatment 3(1), 1-13 (2004).
30. Lester B, Andreozzi L, Appiah L: Substance use during pregnancy: time for policy to catch up with research. Harm Reduct. J. 1(5), 1-44 (2004).
31. Kumpfer KL, Fowler MA: Parenting skills and family support programs for drug-abusing mothers. Semin. Fetal Neonatal Med. 12(2), 134-142 (2007).
32. Porowski A, Burgdorf K, Herrell J: Effectiveness and sustainability of residential substance abuse treatment programs for pregnant and parenting women. Eval. Program Plann. 27, 191-198 (2004).
33. McComish JF, Greenberg R, Ager J et al.: Family-focused substance abuse treatment: a program evaluation. J Psychoactive Drugs 35(3), 321-331 (2003).
34. Marsh JC, Cao D, D'Aunno T: Gender differences in the impact of comprehensive services in substance abuse treatment. J. Subst. Abuse Treat. 27(4), 289-300 (2004).
35. Niccols A, Sword W: "New choices" for substance-using mothers and their children: preliminary evaluation. J. Subst. Abuse 10(4), 239-251 (2005).
36. Suffet F, Brotman R: A comprehensive care program for pregnant addicts: obstetrical, neonatal and child development outcomes. Int. J. Addict. 19, 199-219 (1984).
37. Jones H: Drug addiction during pregnancy. Curr. Dir. Psychol. Sci. 15(3), 126-130 (2006).
38. Grella CE, Greenwell L: Substance abuse treatment for women: changes in the settings where women received treatment and types of services provided, 1987-1998. J. Behav. Health Serv. Res. 31(4), 367-383 (2004).
39. Campbell CI, Wells R, Alexander JA et al.: Tailoring of outpatient substance abuse treatment to women, 1995-2005. Med. Care 45(8), 775-780 (2007).
40. Black MM, Nair P, Knight C et al.: Parenting and early development among children of drug-abusing women: effects of home intervention. Pediatrics 94(4 Pt 1), 440-448 (1994).
41. Grant T, Ernst C, Pagalilauan G, Streissguth A: Post program follow-up effects of paraprofessional intervention with high-risk women who abused alcohol and drugs during pregnancy. J. Community Psychol. 31 (3), 211-222 (2003).
42. Schuler ME, Nair P, Black MM: Ongoing maternal drug use, parenting attitudes, and a home intervention: effects on mother-child interaction at 18 months. J. Dev. Behav. Pediatr. 23(2), 87-94 (2002).
43. Nair P, Schuler ME, Black MM, Kettinger L, Harrington D: Cumulative environmental risk in substance abusing women: early intervention, parenting stress, child abuse potential and child development. Child Abuse Negl. 27(9), 997-1017 (2003).
44. Jansson LM, Svikis DS, Beilenson P: Effectiveness of child case management services for offspring of drug-dependent women. Subst. Use Abuse 38(14), 1933-1952 (2003).
45. Mullins SM, Suarez M, Ondersma SJ, Page MC: The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J. Subst. Abuse Treat 27(1), 51-58 (2004).
46. Ondersma S, Svikis D, Schuster C: Computer-based brief intervention: a randomized trial with postpartum women. Am. J. Prev. Med. 32(3), 231-238 (2007).
47. Ondersma SJ, Chase SK, Svikis DS, Schuster CR: Computer-based brief motivational intervention for perinatal drug use. J. Subst. Abuse Treat 28(4), 305-312 (2005).
48. Jones HE, Svikis DS, Tran G: Patient compliance and maternal/infant outcomes in pregnant drug-using women. Subst. Use Misuse 37(11), 1411-1422 (2002).
49. Motz M, Leslie M, DeMarchi G: Breaking the cycle: using a relational approach to address the impact of maternal substance use on regulation and attachment in children. Zero to Three 27(4), 19-25 (2007).
50. Sword W, Niccols A, Fan A: "New choices" for women with addictions: perceptions of program participants. BMC Public Health 4, 10 (2004).
51. Kem JK, West EY, Grannemann BD et al.: Reductions in stress and depressive symptoms in mothers of substance-exposed infants, participating in a psychosocial program. Matern. Child Health J. 8(3), 127-136 (2004).
52. Velez ML, Jansson LM, Montoya ID et al.: Parenting knowledge among substance abusing women in treatment. J. Subst. Abuse Treat. 27(3), 215-222 (2004).
53. Rayburn WF, Bogenschutz MP: Pharmacotherapy for pregnant women with addictions. Am. J. Obstet Gynecol. 191(6), 1885-1897 (2004).
54. Jones H: Practical considerations for the clinical use of buprenorphine. Sci. Pract. Perspect. August, 4-23 (2004).
55. Fischer G, Ortner R, Rohrmeister K et al.: Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 101(2), 275-281 (2006).
56. Green B, Rockhill A, Furrer C: Does substance abuse treatment make a difference for child welfare case outcomes: a statewide longitudinal analysis. Child Youth Serv. Rev. 29(4), 460-473 (2007).
57. Green BL, Furrer C, Worcel S, Burrus S, Finigan MW: How effective are family treatment drug courts? Outcomes from a four-site national study. Child Maltreat. 12(1), 43-59 (2007).
58. Gregoire KA, Schultz DJ: Substance-abusing child welfare parents: treatment and child placement outcomes. Child Welfare 80(4), 433-452 (2001).
59. Jeremiah J Jr: The Rhode Island Family Courts therapeutic response to parental substance abuse. Medicine & Health Rhode Island 20(2), 20-29 (2007).
60. Price-Colen L: The Zero Exposure Project: a community initiative addressing substance abusing women and their newborns. Zero to Three 27(4), 49-54 (2007).
61. Fals-Stewart W, Kelley ML, Fincham FD, Golden J, Logsdon T: Emotional and behavioral problems of children living with drug-abusing fathers: comparisons with children living with alcohol-abusing and non-substance-abusing fathers. J. Fam. Psychol. 18(2), 319-330 (2004).
62. Kelley ML, Fals-Stewart W. Couples- versus individual-based therapy for alcohol and drug abuse: effects on children's psychosocial functioning. J. Consult. Clin. Psychol. 70(2), 417-427 (2002).
63. McMahon T, Winkel J, Luthar S, Rounsaville B: Looking for Poppa: parenting status of men versus women seeking drug abuse treatment. Am. J. Drug Alcohol Abuse 1, 79-91 (2005).
64. McMahon T, Winkel J, Suchman N, Rounsaville B: Drug-abusing fathers: patterns of pair bonding, reproduction, and paternal involvement. J. Subst. Abuse Treat. 33(3), 295-302 (2007).
65. Twomey J: Partners of perinatal substance users: forgotten, failing, or fit to father? Am. J. Orthopsychiatry (In Press).
66. Twomey J, Lester B: How permanent is permanent placement for substance-exposed infants? Zero to Three 27 (4), 41-48 (2007).
67. Twomey J, Soave R, Gil L, Lester B: Permanency planning and social service systems: a comparison of two families with prenatally substance exposed infants. Infant Ment. Health 26(3), 250-267 (2005).
68. French MT, McCollister KE, Cacciola J, Durell J, Stephens RL: Benefit-cost analysis of addiction treatment in Arkansas: specialty and standard residential programs for pregnant and parenting women. Subst. Abus. 23(1), 31-51 (2002).
69. Daley M, Shepard DS, Bury-Maynard D: Changes in quality of life for pregnant women in substance user treatment: developing a quality of life index for the addictions. Subst. Use Misuse 40(3), 375-394 (2005).
70. Lester BM, LaGasse LL, Seifer R: Cocaine exposure and children: the meaning of subtle effects. Science 282, 633-634 (1998).
71. Daley M, Argeriou M, McCarty D et al.: The costs of crime and the benefits of substance abuse treatment for pregnant women. J. Subst. Abuse Treat. 19(4), 445-458 (2000).
72. Camp J, Finkelstein N: Fostering effective parenting skills and healthy child development within residential substance abuse settings. CSAP Final Report (1995).
73. Szuster RR, Rich LL, Chung A, Bisconer SW: Treatment retention in women's residential chemical dependency treatment: the effect of admission with children. Subst. Use Misuse 31(8), 1001-1013 (1996).
74. Stevens S, Arbiter N, Glider P: Women residents: expanding their role to increase treatment effectiveness in substance abuse. Int. J. Addict. 24(55), 425-434 (1989).
75. Hughes PH, Coletti SD, Neri RL et al.: Retaining cocaine-abusing women in a therapeutic community: the effect of a child live-in program. Am. J. Public Health 85(8 Pt 1), 1149-1152 (1995).
76. Haller D, Elswick R Jr, Dawson K, Knisely Schnoll S: Retention in treatment of perinatal substance abusers. National Institute on Drug Abuse Research Monograph 132. NIH Pub. No. 93-3505 (1993).
77. Strantz IH, Welch SP: Postpartum women in outpatient drug abuse treatment: correlates of retention/completion. J. Psychoactive Drugs 27(4), 357-373 (1995).
78. Brindis CD, Theidon KS: The role of case management in substance abuse treatment services for women and their children. Psychoactive Drugs 29(1), 79-88 (1997).